Fundz

Flight Path Biosciences reported raising $1.1 Million in an initial SEC Form D filing, from an offering of $8 Million

PRIVATEFeb 15, 2023$1.1M of $8M raised

Amount Raised

$1.1 Million

$1.1 Million sold, per SEC Form D (first sale Feb 13, 2023)

Round Type

Seed

BirminghamBiotechnology

Quick answer

FlightPath Biosciences, Inc. raised $1.1 Million in a Seed round, dated February 13, 2023. FlightPath Biosciences, Inc. is based in Birmingham, Michigan, United States.

How much did FlightPath Biosciences, Inc. raise?
FlightPath Biosciences, Inc. raised $1.1 Million in a Seed round on February 13, 2023.
What does FlightPath Biosciences, Inc. do?
Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.
Where is FlightPath Biosciences, Inc. based and how big is it?
FlightPath Biosciences, Inc. is based in Birmingham, Michigan, United States.
Who are the decision-makers at FlightPath Biosciences, Inc?
Fundz holds 1 contact at FlightPath Biosciences, Inc., including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as FlightPath Biosciences, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • EMIT Imaging raised $7.1M on March 30, 2023.
  • Gregor Diagnostics raised $4.4M (Seed) on March 30, 2023.
  • Arialys Therapeutics raised $10M (Series A) on March 30, 2023.
  • Trobix Bio raised $3M (Seed) on March 30, 2023.
  • GlycosBio raised $425K (Seed) on March 30, 2023.
  • Delcath Systems raised $25M on March 29, 2023.

Who to call at FlightPath Biosciences, Inc., and when

A new round usually means FlightPath Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day FlightPath Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at FlightPath Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at FlightPath Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

FlightPath Biosciences, Inc.

Location

15 Fairfax Street

Birmingham, Michigan, United States

About

Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment FlightPath Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAlison L., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for FlightPath Biosciences, Inc.'s next move

See what Strategic adds

FlightPath Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.